The application of stem cells in the treatment of ischemic diseases

Histology and Histopathology

Volumn 21, Issue 10-12, 2006, Pages 1209-1216

  Chen, C P ^a   Lee, Y J ^b   Chiu, S T ^c,d   Shyu, W C ^d   Lee, M Y ^a   Huang, S P ^e   Li, Hung ^f  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e WASHINGTON UNIVERSITY   (United States)

^f INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

Author keywords

Ischemic diseases; Stem cells

Indexed keywords

GADOLINIUM PENTETATE; GRANULOCYTE COLONY STIMULATING FACTOR; OXYGEN; STROMAL CELL DERIVED FACTOR 1; TRYPTOPHAN TRANSFER RNA LIGASE;

ANGIOGENESIS; CELL DAMAGE; CELL DIFFERENTIATION; CELL TYPE; EMBRYONIC STEM CELL; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIA; KIDNEY FAILURE; KIDNEY ISCHEMIA; LIMB ISCHEMIA; LIVER ISCHEMIA; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; RETINA ISCHEMIA; REVIEW; STEM CELL TRANSPLANTATION; STROKE; TISSUE INJURY; TISSUE REGENERATION; TISSUE REPAIR; ANIMAL; CELL LINEAGE; CEREBROVASCULAR ACCIDENT; CYTOLOGY; LIVER DISEASE; METHODOLOGY; MOUSE; PATHOLOGY; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CEREBROVASCULAR ACCIDENT; HEMATOPOIETIC STEM CELLS; HUMANS; ISCHEMIA; LIVER DISEASES; MICE; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33750308535     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M. and Isner J.M. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221-228.
2. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J. and Penn M.S. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697-703.
3. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Grunwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S. and Zeiher A.M. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106, 3009-3017.
4. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L. and Robbins R.C. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668-673.
5. Burgos R., Simo R., Audi L., Mateo C., Mesa J., Garcia-Ramirez M. and Carrascosa A. (1997). Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 40, 1107-1109.
6. Cogle C.R., Guthrie S.M., Sanders R.C., Allen W.L., Scott E.W. and Petersen B.E. (2003). An overview of stem cell research and regulatory issues. Mayo Clin. Proc. 78, 993-1003.
7. Cotran R.S., Kumar V., Robbins S.L. and Schoen F.J. (1994). Robbins pathologic basis of disease. W.B. Saunders. pp 1-35
8. Crich S.G., Biancone L., Cantaluppi V., Duo D., Esposito G., Russo S., Camussi G. and Aime S. (2004). Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn. Reson. Med. 51, 938-944.
9. Davani S., Marandin A., Mersin N., Royer B., Kantelip B., Herve P., Etievent J.P. and Kantelip J.P. (2003). Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108 Suppl 1, II253-258.
10. Dawn B., Stein A.B., Urbanek K., Rota M., Whang B., Rastaldo R., Torella D., Tang X.L., Rezazadeh A., Kajstura J., Leri A., Hunt G., Varma J., Prabhu S.D., Anversa P. and Bolli R. (2005). Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl. Acad. Sci. USA 102, 3766-3771.
11. Demetri G.D. and Griffin J.D. (1991). Granulocyte colony-stimulating factor and its receptor. Blood 78, 2791-2808.
12. Elfenbein G.J. and Sackstein R. (2004). Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. Exp. Hematol. 32, 327-339.
13. Ffytche T.J. (1974). A rationalization of treatment of central retinal artery occlusion. Trans. Ophthalmol. Soc. UK 94, 468-479.
14. Frank J.A., Zywicke H., Jordan E.K., Mitchell J., Lewis B.K., Miller B., Bryant L.H. Jr. and Bulte J.W. (2002). Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad. Radiol. 9, S484-487.
15. Grant M.B., May W.S., Caballero S., Brown G.A., Guthrie S.M., Marnes R.N., Byrne B.J., Vaught T., Spoerri P.E., Peck A.B. and Scott E.W. (2002). Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8, 607-612.
16. Guo Y., Saloupis P., Shaw S.J. and Rickman D.W. (2003). Engraftment of adult neural progenitor cells transplanted to rat retina injured by transient ischemia. Invest. Ophthalmol. Vis. Sci. 44, 3194-3201.
17. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., Hackett N.R., Quitoriano M.S., Crystal R.G., Rafii S. and Moore M.A. (2001). Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97, 3354-3360.
18. Hattori K., Heissig B., Wu Y., Dias S., Tejada R., Ferris B., Hicklin D.J., Zhu Z., Bohlen P., Witte L., Hendrikx J., Hackett N.R., Crystal R.G., Moore M.A., Werb Z., Lyden D. and Rafii S. (2002). Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8, 841-849.
19. Hayreh S.S. (1995). The 1994 Von Sallman Lecture. The optic nerve head circulation in health and disease. Exp. Eye Res. 61, 259-272.
20. Hayreh S.S. and Podhajsky P. (1982). Ocular neovascularization with retinal vascular occlusion. II. Occurrence in central and branch retinal artery occlusion. Arch. Ophthalmol. 100, 1585-1596.
21. Heeschen C., Aicher A., Lehmann R., Fichtischerer S., Vasa M., Urbich C., Mildner-Rihm C., Martin H., Zeiher A.M. and Dimmeler S. (2003). Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346.
22. Hofman P., van Blijswijk B.C., Gaillard P.J., Vrensen G.F. and Schlingemann R.O. (2001). Endothelial cell hypertrophy induced by vascular endotheliall growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion. Arch. Ophthalmol. 119, 861-866.
23. Horslen S.P. and Fox I.J. (2004). Hepatocyte transplantation. Transplantation 77, 1481-1486.
24. Jang Y.Y., Collector M.I., Baylin S.B., Diehl A.M. and Sharkis S.J. (2004). Hematopoietic stem cells convert into liver cells within days without fusion. Nat. Cell Biol. 6, 532-539.
25. Kajstura J., Rota M., Whang B., Cascapera S., Hosoda T., Bearzi C., Nurzynska D., Kasahara H., Zias E., Bonafe M., Nadal-Ginard B., Torella D., Nascimbene A., Quaini F., Urbanek K., Leri A. and Anversa P. (2005). Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. 96, 127-137.
26. Kakinuma S., Tanaka Y., Chinzei R., Watanabe M., Shimizu-Saito K., Hara Y., Teramoto K., Arii S., Sato C., Takase K., Yasumizu T. and Teraoka H. (2003). Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 21, 217-227.
27. Kamihata H., Matsubara H., Nishiue T., Fujiyama S., Tsutsumi Y., Ozono R., Masaki H., Mori Y., Iba O., Tateishi E., Kosaki A., Shintani S., Murohara T., Imaizumi T. and Iwasaka T. (2001). Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104, 1046-1052.
28. Kinnaird T., Stabile E., Burnett M.S., Shou M., Lee C.W., Barr S., Fuchs S. and Epstein S.E. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543-1549.
29. Kuai X.L., Cong X.Q., Li X.L. and Xiao S.D. (2003). Generation of hepatocytes from cultured mouse embryonic stem cells. Liver Transpl. 9, 1094-1099.
30. Kucia M., Dawn B., Hunt G., Guo Y., Wysoczynski M., Majka M., Ratajczak J., Rezzoug F., Ildstad S.T., Bolli R. and Ratajczak M.Z. (2004). Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ. Res. 95, 1191-1199.
31. Kurimoto Y., Shibuki H., Kaneko Y., Ichikawa M., Kurokawa T., Takahashi M. and Yoshimura N. (2001). Transplantation of adult rat hippocampus-derived neural stem cells into retina injured by transient ischemia. Neurosci. Lett. 306, 57-60.
32. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., Wang X., Finegold M., Weissman I.L. and Grompe M. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6, 1229-1234.
33. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N. and Chopp M. (2002). Human marrow stromal cell therapy for stroke in rat: neurotrophins; and functional recovery. Neurology 59, 514-523.
34. Masson S., Harrison D.J., Plevris J.N. and Newsome P.N. (2004). Potential of hematopoietic stem cell therapy in hepatology: a critical review. Stem Cells 22, 897-907.
35. Modo M., Mellodew K., Cash D., Fraser S.E., Meade T.J., Price J. and Williams S.C. (2004). Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 21, 311-317.
36. Muller-Ehmsen J., Whittaker P., Kloner R.A., Dow J.S., Sakoda T., Long T.I., Laird P.W. and Kedes L. (2002). Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell Cardiol. 34, 107-116.
37. Nygren J.M., Jovinge S., Breitbach M., Sawen P., Roll W., Hescheler J., Taneera J., Fleischmann B.K. and Jacobsen S.E. (2004). Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10, 494-501.
38. Orkin S.H. and Zon L.I. (2002). Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat. Immunol. 3, 323-328.
39. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Led A. and Anversa P. (2001a). Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705.
40. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Led A. and Anversa P. (2001b). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98, 10344-10349.
41. Osborne N.N., Casson R.J., Wood J.P., Chidlow G., Graham M. and Melena J. (2004). Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91-147.
42. Otani A., Kinder K., Ewalt K., Otero F.J., Schimmel P. and Friedlander M. (2002). Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8, 1004-1010.
43. Overturf K., Al-Dhalimy M., Finegold M. and Grompe M. (1999). The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am. J. Pathol. 155, 2135-2143.
44. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., Rossi M.I., Carvalho A.C., Dutra H.S., Dohmann H.J., Silva G.V., Belem L., Vivacqua R., Rangel F.O., Esporcatte R., Geng Y.J., Vaughn W.K., Assad J.A., Mesquita. E.T. and Willerson J.T. (2003). Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107, 2294-2302.
45. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M., Sullivan A.K., Murase N., Boggs S.S., Greenberger J.S. and Goff J.P. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284, 1168-1170.
46. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., Ponomaryov T., Taichman R.S., Arenzana-Seisdedos F., Fujii N., Sandbank J., Zipori D. and Lapidot T. (2002). G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687-694.
47. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S. and Marshak D.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284,143-147.
48. Reinecke H., Zhang M., Bartosek T. and Murry C.E. (1999). Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100, 193-202.
49. Sakaguchi Y., Sekiya I., Yagishita K. and Muneta T. (2005). Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 52, 2521-2529.
50. Schatteman G.C., Hanlon H.D., Jiao C., Dodds S.G. and Christy B.A. (2000). Blood-derived angioblasts; accelerate blood-flow restoration in diabetic mice. J. Clin. Invest. 106, 571-578.
51. Schuster M.D., Kocher A.A., Seki T., Martens T.P., Xiang G., Homma S. and Itescu S. (2004). Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte, regeneration. Am. J. Physiol. Heart Circ. Physiol. 287, H525-532.
52. Shyu W.C., Lin S.Z., Yang H.I., Tzeng Y.S., Pang C.Y., Yen P.S. and Li H. (2004). Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 110, 1847-1854.
53. Sigurjonsson O.E., Perreault M.C., Egeland T. and Glover J.C. (2005). Adult human hematopoietic stem cells produce neurons efficiently in the regenerating chicken embryo spinal cord. Proc. Natl. Acad. Sci. USA 102, 5227-5232.
54. Smith L.E. (2002). Stem cells go for the eyes. Nat. Med. 8, 932-934.
55. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., Kogler G. and Wernet P. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-1918.
56. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M. and Asahara T. (1999). Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438.
57. Tang Y.L., Zhao Q., Qin X., Shen L., Cheng L., Ge J. and Phillips M.I. (2005). Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann. Thorac. Surg. 80, 229-236; discussion 236-227.
58. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., Glower D.D. and Kraus W.E. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4, 929-933.
59. Terai S., Sakaida I., Yamamoto N., Omori K., Watanabe T., Ohata S., Katada T., Miyamoto K., Shinoda K., Nishina H. and Okita K. (2003). An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J. Biochem. (Tokyo). 134, 551-558.
60. Theise N.D., Nimmakayalu M., Gardner R., Illei P.B., Morgan G., Teperman L., Henegariu O. and Krause D.S. (2000). Liver from bone marrow in humans. Hepatology 32, 11-16.
61. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S. and Jones J.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
62. Togel F., Hu Z., Weiss K., Isaac J., Lange C. and Westenfelder C. (2005a). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal Physiol. 289, F31-42.
63. Togel F., Isaac J., Hu Z., Weiss K. and Westenfelder C. (2005b). Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 67, 1772-1784.
64. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J. and Kessler P.D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98.
65. Tomita S., Li R.K., Weisel R.D., Mickle D.A., Kim E.J., Sakai T. and Jia Z.Q. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, 11247-256.
66. van Gijn J. and Dennis M.S. (1998). Issues and answers in stroke care. Lancet 352 Suppl 3, SIII23-27.
67. Vandervelde S., van Luyn M.J., Tio R.A. and Harmsen M.C. (2005). Signaling factors in stem cell-mediated repair of infarcted myocardium. J. Mol. Cell. Cardiol. 39, 363-376.
68. Vassilopoulos G., Wang P.R. and Russell D.W. (2003). Transplanted bone marrow regenerates liver by cell fusion. Nature 422, 901-904.
69. Vincent K.A., Feron O. and Kelly R.A. (2002). Harnessing the response to tissue hypoxia: HIF-1 alpha and therapeutic angiogenesis. Trends Cardiovasc. Med. 12, 362-367.
70. Wang H.S., Hung S.C., Peng S.T., Huang C.C., Wei H.M., Guo Y.J., Fu Y.S., Lai M.C. and Chen C.C. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22, 1330-1337.
71. Wang J.S., Shum-Tim D., Galipeau J., Chedrawy E., Eliopoulos N. and Chiu R.C. (2000). Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 120, 999-1005.
72. Wang X., Montini E., Al-Dhalimy M., Lagasse E., Finegold M. and Grompe M. (2002). Kinetics of liver repopulation after bone marrow transplantation. Am. J. Pathol. 161, 565-574.
73. Willenbring H., Bailey A.S., Foster M., Akkari Y., Dorrell C., Olson S., Finegold M., Fleming W.H. and Grompe M. (2004). Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat. Med. 10, 744-748.
74. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A. and Drexler H. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148.